Citation: | MA Xu-can, DING Ying-wei, ZHANG Bing-wen. Effect of gamma globulin pulse therapy on patients with severe community-acquired pneumonia and on serum immune proteins and lymphocyte subsets[J]. Chinese Journal of General Practice, 2021, 19(9): 1497-1499,1583. doi: 10.16766/j.cnki.issn.1674-4152.002095 |
[1] |
LANKS C W, MUSANI A I, HSIA D W. Community-acquired pneumonia and hospital-acquired pneumonia[J]. Med Clin North Am, 2019, 103(3): 487-501. doi: 10.1016/j.mcna.2018.12.008
|
[2] |
TORRES A, CHALMERS J D, DELA C C, et al. Challenges in severe community-acquired pneumonia: A point-of-view review[J]. Intensive Care Med, 2019, 45(2): 159-171. doi: 10.1007/s00134-019-05519-y
|
[3] |
马文君, 贾换. 丙种球蛋白联合地塞米松治疗重症肺炎的效果[J]. 河南医学研究, 2020, 29(7): 1259-1260. doi: 10.3969/j.issn.1004-437X.2020.07.054
|
[4] |
YANG L, WU E Y, TARRANT T K. Immune gamma globulin therapeutic indications in immune deficiency and autoimmunity[J]. Curr Allergy Asthma Rep, 2016, 16(8): 55. doi: 10.1007/s11882-016-0632-7
|
[5] |
中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J]. 中华结核和呼吸杂志, 2016, 39(4): 253-279. doi: 10.3760/cma.j.issn.1001-0939.2016.04.005
|
[6] |
RIDER A C, FRAZEE B W. Community-acquired pneumonia[J]. Emerg Med Clin North Am, 2018, 36(4): 665-683. doi: 10.1016/j.emc.2018.07.001
|
[7] |
张颜苹, 霍建民, 陈晓灿. 成人社区获得性肺炎病情评估的研究进展[J]. 临床肺科杂志, 2020, 25(1): 143-146. https://www.cnki.com.cn/Article/CJFDTOTAL-LCFK202001035.htm
|
[8] |
GARNACHO-MONTERO J, BARRERO-GARCIA I, GOMEZ-PRIETO M G, et al. Severe community-acquired pneumonia: Current management and future therapeutic alternatives[J]. Expert Rev Anti Infect Ther, 2018, 16(9): 667-677. doi: 10.1080/14787210.2018.1512403
|
[9] |
WUNDERINK R G. Guidelines to manage community-acquired pneumonia[J]. Clin Chest Med, 2018, 39(4): 723-731. doi: 10.1016/j.ccm.2018.07.006
|
[10] |
李海. 糖皮质激素对重症社区获得性肺炎合并脓毒性休克患者的治疗效果分析[J]. 河南医学研究, 2018, 27(11): 2014-2015. doi: 10.3969/j.issn.1004-437X.2018.11.048
|
[11] |
李洁, 陈滔. 人血丙种球蛋白对儿童难治性肺炎支原体肺炎的作用效果[J]. 中国妇幼保健, 2020, 35(7): 1267-1269. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202007034.htm
|
[12] |
RAMUS B, BENBRAHIM O, CHERIN P. Use of intravenous and subcutaneous human immunoglobulins[J]. Soins, 2019, 64(833): 13-18. doi: 10.1016/j.soin.2019.01.016
|
[13] |
褚祝飞, 魏利锋, 周超群. 丙种球蛋白对支原体肺炎合并肺不张患儿免疫功能、炎性指标的影响[J]. 现代实用医学, 2020, 32(3): 360-362. doi: 10.3969/j.issn.1671-0800.2020.03.037
|
[14] |
LEONI D, RELLO J. Severe community-acquired pneumonia: Optimal management[J]. Curr Opin Infect Dis, 2017, 30(2): 240-247. doi: 10.1097/QCO.0000000000000349
|
[15] |
黄宏佳, 罗海清, 郑文枝, 等. C反应蛋白在社区获得性肺炎严重程度和预后评估中的作用[J]. 实用心脑肺血管病杂志, 2018, 26(2): 99-101. https://www.cnki.com.cn/Article/CJFDTOTAL-SYXL2018S2044.htm
|
[16] |
谢君杰, 易汛, 徐昉. 临床肺部感染评分和降钙素原对评估老年重症社区获得性肺炎患者病情和预后的意义[J]. 中华实验和临床感染病杂志(电子版), 2018, 12(1): 61-64. doi: 10.3877/cma.j.issn.1674-1358.2018.01.012
|
[17] |
CATAUDELLA E, GIRAFFA C M, DIMARCA S, et al. Neutrophil-to-lymphocyte ratio: An emerging marker predicting prognosis in elderly adults with community-acquired pneumonia[J]. J Am Geriatr Soc, 2017, 65(8): 1796-1801. doi: 10.1111/jgs.14894
|
[18] |
代岩. 丙种球蛋白对重症肺炎患者血清细胞因子及免疫功能的影响[J]. 中国临床医生杂志, 2018, 46(7): 772-774. doi: 10.3969/j.issn.2095-8552.2018.07.006
|
[19] |
GUELL E, MARTIN-FERNANDEZ M, DELATORRE M C, et al. Impact of lymphocyte and neutrophil counts on mortality risk in severe community-acquired pneumonia with or without septic shock[J]. J Clin Med, 2019, 8(5): 754. doi: 10.3390/jcm8050754
|